72.19.Z - Scientific research and development activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | -14,5 | -9,2 | 36,5 |
EBITDA | 0 | |||
Short time liabilities | 0 | |||
Income tax | 0 | 0 | 0 | |
Equity capital | 5 | -9,5 | -18,6 | -97,1 |
Operating profit (EBIT) | 0 | |||
Assets | 5 | 5,6 | 3,9 | -30,4 |
Net profit (loss) | 0 | -14,5 | -9,2 | 36,5 |
Cash | 5 | |||
Net income from sale | 0 | |||
Liabilities and provisions for liabilities | 0 | 15,1 | 22,5 | 49,6 |
Working assets | 5 | 5,6 | 3,9 | -30,4 |
Basic operational activity income | 0 | 1,5 | -∞ | |
Depreciation | 0 | |||
% | % | % | p.p. | |
Profitability of capital | 0 | |||
Equity capital to total assets | 100 | -168,3 | -476,5 | -308,2 |
Gross profit margin | -611,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane